A Systematic Review of Cardiovascular Outcomes-Based Cost-Effectiveness Analyses of Lipid-Lowering Therapies

Ching-Yun Wei*, Ruben G. W. Quek, Guillermo Villa, Shravanthi R. Gandra, Carol A. Forbes, Steve Ryder, Nigel Armstrong, Sohan Deshpande, Steven Duffy, Jos Kleijnen, Peter Lindgren

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)297-318
Number of pages22
JournalPharmacoeconomics
Volume35
Issue number3
DOIs
Publication statusPublished - Mar 2017

Keywords

  • CORONARY-HEART-DISEASE
  • AVERAGE CHOLESTEROL LEVELS
  • QUALITY-OF-LIFE
  • RANDOMIZED CONTROLLED-TRIAL
  • ACUTE MYOCARDIAL-INFARCTION
  • HIGH-DOSE ATORVASTATIN
  • DENSITY-LIPOPROTEIN CHOLESTEROL
  • ARTERY BYPASS-SURGERY
  • HIGH-RISK PATIENTS
  • SECONDARY PREVENTION

Cite this

Wei, C-Y., Quek, R. G. W., Villa, G., Gandra, S. R., Forbes, C. A., Ryder, S., Armstrong, N., Deshpande, S., Duffy, S., Kleijnen, J., & Lindgren, P. (2017). A Systematic Review of Cardiovascular Outcomes-Based Cost-Effectiveness Analyses of Lipid-Lowering Therapies. Pharmacoeconomics, 35(3), 297-318. https://doi.org/10.1007/s40273-016-0464-2